ALS Worldwide welcomes any questions or comments you might have.  We provide free, personalized and confidential support services to anyone in the ALS community—whether you are a patient or a loved one, friend, health care professional or caregiver of someone diagnosed.

Get help now! Fill out the Online Profile Form or if you would prefer to talk with someone by email or phone first, please contact us at [email protected] or 1-608-663-0920.

For all other inquiries, please use the email form to the right and we will respond promptly to your request.Thank you.

ALS Worldwide
5808 Dawley Drive
Fitchburg, WI 53711‑7209

ALS Worldwide
Sorted by category: Clinical Trials | View All
September 25, 2015

The FDA Drug Approval Process

A brief, charted explanation of how a drug becomes approved by the FDA.

September 16, 2015

Do Clinical Trials Work?

Clinical trials are a critical part of getting a drug approved by the FDA - but since they often come under fire due to their low success rates, it's time to take a new direction.

July 30, 2015

United Kingdom Commitment to ALS/MND

United Kingdom Commitment to ALS/MND, made possible by The Sharna and Irvin Frank Foundation, reflects extensive research by Barbara and Stephen Byer. 

June 14, 2015

On The Horizon

Developments in ALS/MND research move at a swift pace, from skin providing diagnostic tissue to stem cell clinical trials about to receive FDA approval.   

March 16, 2015

Why Upper Motor Neurons Degenerate in ALS

Hande Ozdinler, Ph.D. at Northwestern University, has presented a new paper that supports and advances earlier studies that suggest ALS begins in the brain rather than the spinal cord.

January 30, 2015

Neuralstem Clinical Trials

Dr. Eva Feldman, principal investigator of the ongoing Neuralstem Clinical Trials, and Neuralstem officers appear enthusiastic about Phase II clinical trial results.